N-2749

N/A

Report date: 2022/08/23 20:00:44

NME

Base Information

Drug NameN-2749

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOsteoporosis, Postmenopausal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNisshin Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNisshin Pharma

Active IndicationsN/A

Inactive IndicationsOsteoporosis, Postmenopausal

ATC CodeN/A